Skip to main content
SpringerLink
Log in

Pain Management in the Colorectal Cancer Patient

  • Chapter
Colorectal Cancer

Part of the book series: Current Clinical Oncology ((CCO))

Abstract

Pain management is a critical component of the treatment of advanced colorectal cancer. In this chapter, a set of core principles is outlined to assist in the diagnosis and treatment of most causes of pain in the colorectal cancer patient. An algorithmic approach is described to facilitate expeditious and efficacious treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. International Association for the Study of Pain Website-Pain Terminology; http://www. iasp-pain.org/terms-p.html#Pain. 2004. Date accessed: 10/1/2004.

  2. Portenoy RK. Cancer pain. Epidemiology and syndromes. Cancer 1989;63(11 Suppl):2298–2307.

    Article  PubMed  CAS  Google Scholar 

  3. Foley KM. Pain syndromes in patients with cancer. Med Clin North Am 1987;71(2):169–184.

    PubMed  CAS  Google Scholar 

  4. Fitzgibbon DR. Cancer Pain: Management. In: Bonica’s Management of Pain, 3rd ed. (Loeser JD, ed.), Philapdelphia, Lippincott Williams & Wilkins, 2001, pp. 659–673.

    Google Scholar 

  5. Dewar JA. Managing metastatic bone pain. BMJ 2004;329(7470):812–813.

    Article  PubMed  Google Scholar 

  6. Przewlocki R, Przewlocka B. Opioids in chronic pain. Eur J Pharmacol 2001;429(1-3):79–91.

    Article  PubMed  CAS  Google Scholar 

  7. Bennett GJ. Neuropathic pain: new insights, new interventions. Hosp Pract (Off Ed) 1998;33(10):95–98, 101-104, 7-10 passim.

    CAS  Google Scholar 

  8. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353(9168):1959–1964.

    Article  PubMed  CAS  Google Scholar 

  9. Regan JM, Peng P. Neurophysiology of cancer pain. Cancer Control 2000;7(2):111–119.

    PubMed  CAS  Google Scholar 

  10. McQuay HJ. Pharmacological treatment of neuralgic and neuropathic pain. Cancer Surv 1988;7(1):141–159.

    PubMed  CAS  Google Scholar 

  11. Breivik H. Opioids in cancer and chronic non-cancer pain therapy-indications and controversies. Acta Anaesthesiol Scand 2001;45(9):1059–1066.

    Article  PubMed  CAS  Google Scholar 

  12. Rocco AG, Chan V, Iacobo C. An algorithm for the treatment of pain in advanced cancer. Hosp J 1989;5(3-4):93–103.

    PubMed  CAS  Google Scholar 

  13. Camu F, Shi L, Vanlersberghe C. The role of COX-2 inhibitors in pain modulation. Drugs 2003;63 Suppl 1:1–7.

    Article  PubMed  CAS  Google Scholar 

  14. Cicconetti A, Bartoli A, Ripari F, Ripari A. COX-2 selective inhibitors: a literature review of analgesic efficacy and safety in oral-maxillofacial surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97(2):139–146.

    Article  PubMed  Google Scholar 

  15. Desmeules JA, Cedraschi C, Piguet V, Allaz AF, Dayer P. Advances with analgesics and NSAIDs for the treatment of spinal disorders. Best Pract Res Clin Rheumatol 2002; 16(1):105–121.

    Article  PubMed  CAS  Google Scholar 

  16. Hutchison R. COX-2—selective NSAIDs. Am J Nurs 2004;104(3):52–55; quiz 5–6.

    PubMed  Google Scholar 

  17. Romsing J, Moiniche S. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain. Acta Anaesthesiol Scand 2004;48(5):525–546.

    Article  PubMed  CAS  Google Scholar 

  18. Bovill JG. Pharmacology and clinical action of COX-2 selective NSAIDs. Adv Exp Med Biol 2003;523:201–214.

    PubMed  CAS  Google Scholar 

  19. Kaplan-Machlis B, Klostermeyer BS. The cyclooxygenase-2 inhibitors: safety and effectiveness. Ann Pharmacother 1999;33(9):979–988.

    Article  PubMed  CAS  Google Scholar 

  20. Krum H, Liew D, Aw J, Haas S. Cardiovascular effects of selective cyclooxygenase-2 inhibitors. Expert Rev Cardiovasc Ther 2004;2(2):265–270.

    Article  PubMed  CAS  Google Scholar 

  21. Malhotra S, Pandhi P, Shafiq N. COX-2 inhibitors: a CLASS act or just VIGORously promoted. MedGenMed 2004;6(1):6.

    PubMed  Google Scholar 

  22. Mukherjee D, Topol EJ. Cox-2: where are we in 2003?-Cardiovascular risk and Cox-2 inhibitors. Arthritis Res Ther 2003;5(1):8–11.

    Article  PubMed  CAS  Google Scholar 

  23. Wright JM. The double-edged sword of COX-2 selective NSAIDs. CMAJ 2002;167(10):1131–1137.

    PubMed  Google Scholar 

  24. Conte P, Coleman R. Bisphosphonates in the treatment of skeletal metastases. Semin Oncol 2004;31(5 Suppl 10):59–63.

    Article  PubMed  CAS  Google Scholar 

  25. Widler L, Jaeggi KA, Glatt M, et al. Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa). J Med Chem 2002;45(17):3721–3738.

    Article  PubMed  CAS  Google Scholar 

  26. Roos DE, Fisher RJ. Radiotherapy for painful bone metastases: an overview of the overviews. Clin Oncol (R Coll Radiol) 2003;15(6):342–344.

    CAS  Google Scholar 

  27. Roberge R. Chronic acetaminophen toxicity. J Emerg Med 2003; 25(4):474.

    Article  PubMed  Google Scholar 

  28. Makin MK. Strong opioids for cancer pain. J R Soc Med 2001;94(1):17–21.

    PubMed  CAS  Google Scholar 

  29. Vallerand AH. The use of long-acting opioids in chronic pain management. Nurs Clin North Am 2003;38(3):435–445.

    Article  PubMed  Google Scholar 

  30. Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J Pain Symptom Manage 2003;26(5):1026–1048.

    Article  PubMed  CAS  Google Scholar 

  31. Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 2004(3):CD004847.

    PubMed  Google Scholar 

  32. Brant JM. Opioid equianalgesic conversion: the right dose. Clin J Oncol Nurs 2001;5(4):163–165.

    PubMed  CAS  Google Scholar 

  33. Mercadante S. Opioid rotation for cancer pain: rationale and clinical aspects. Cancer 1999;86(9):1856–1866.

    Article  PubMed  CAS  Google Scholar 

  34. Thomsen AB, Becker N, Eriksen J. Opioid rotation in chronic non-malignant pain patients. A retrospective study. Acta Anaesthesiol Scand 1999;43(9):918–923.

    Article  PubMed  CAS  Google Scholar 

  35. Derby SA. Opioid conversion guidelines for managing adult cancer pain. Am J Nurs 1999;99(10):62–65.

    Article  PubMed  CAS  Google Scholar 

  36. Attal N. Chronic neuropathic pain: mechanisms and treatment. Clin J Pain 2000;16(3 Suppl):S118–S130.

    PubMed  CAS  Google Scholar 

  37. Bridges D, Thompson SW, Rice AS. Mechanisms of neuropathic pain. Br J Anaesth 2001;87(1):12–26.

    Article  PubMed  CAS  Google Scholar 

  38. Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998;51(4):1166–1171.

    PubMed  CAS  Google Scholar 

  39. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326(19):1250–1256.

    Article  PubMed  CAS  Google Scholar 

  40. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ 1995;311(7012):1047–1052.

    PubMed  CAS  Google Scholar 

  41. Taylor CP. Mechanisms of action of gabapentin. Rev Neurol (Paris) 1997;153 Suppl 1:S39–S45.

    Google Scholar 

  42. Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 2000(3):CD001133.

    PubMed  Google Scholar 

  43. McQuay HJ. Neuropathic pain: evidence matters. Eur J Pain 2002;6 Suppl A:11–18.

    Article  PubMed  Google Scholar 

  44. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003;348(13):1223–1232.

    Article  PubMed  CAS  Google Scholar 

  45. Foley KM. Opioids and chronic neuropathic pain. N Engl J Med 2003;348(13):1279–1281.

    Article  PubMed  Google Scholar 

  46. Spiller HA, Gorman SE, Villalobos D, et al. Prospective multicenter evaluation of tramadol exposure. J Toxicol Clin Toxicol 1997;35(4):361–364.

    Article  PubMed  CAS  Google Scholar 

  47. Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm 2004;61(2):160–173; quiz 75–76.

    PubMed  CAS  Google Scholar 

  48. Ayonrinde OT, Bridge DT. The rediscovery of methadone for cancer pain management. Med J Aust 2000;173(10):536–540.

    PubMed  CAS  Google Scholar 

  49. Foley KM, Houde RW. Methadone in cancer pain management: individualize dose and titrate to effect. J Clin Oncol 1998;16(10):3213–3215.

    PubMed  CAS  Google Scholar 

  50. Nicholson AB. Methadone for cancer pain. Cochrane Database Syst Rev 2004(2):CD003971.

    PubMed  Google Scholar 

  51. Williams JE, Louw G, Towlerton G. Intrathecal pumps for giving opioids in chronic pain: a systematic review. Health Technol Assess 2000;4(32):iii–iv, 1-65.

    PubMed  CAS  Google Scholar 

  52. Miles J. Intrathecal therapy for chronic pain. Stereotact Funct Neurosurg 2001;77(1-4):156–158.

    Article  PubMed  CAS  Google Scholar 

  53. Goldstein FJ. Adjuncts to opioid therapy. J Am Osteopath Assoc 2002;102(9 Suppl 3):S15–S21.

    PubMed  Google Scholar 

  54. Adriaensen H, Vissers K, Noorduin H, Meert T. Opioid tolerance and dependence: an inevitable consequence of chronic treatment? Acta Anaesthesiol Belg 2003;54(1):37–47.

    PubMed  CAS  Google Scholar 

  55. Anderson R, Saiers JH, Abram S, Schlicht C. Accuracy in equianalgesic dosing. Conversion dilemmas. J Pain Symptom Manage 2001;21(5):397–406.

    Article  PubMed  CAS  Google Scholar 

  56. Ballantyne JC. Chronic pain following treatment for cancer: the role of opioids. Oncologist 2003;8(6):567–575.

    Article  PubMed  Google Scholar 

  57. Barkin RL, Buvanendran A. Focus on the COX-1 and COX-2 agents: renal events of nonsteroidal and anti-inflammatory drugs-NSAIDs. Am J Ther 2004;11(2):124–129.

    Article  PubMed  Google Scholar 

  58. Christo PJ. Opioid effectiveness and side effects in chronic pain. Anesthesiol Clin North America 2003;21(4):699–713.

    Article  PubMed  CAS  Google Scholar 

  59. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330(9):592–596.

    Article  PubMed  CAS  Google Scholar 

  60. Cowan DT, Wilson-Barnett J, Griffiths P, Allan LG. A survey of chronic noncancer pain patients prescribed opioid analgesics. Pain Med 2003;4(4):340–351.

    Article  PubMed  Google Scholar 

  61. de Leval X, Julemont F, Benoit V, Frederich M, Pirotte B, Dogne JM. First and second generations of COX-2 selective inhibitors. Mini Rev Med Chem 2004;4(6):597–601.

    PubMed  Google Scholar 

  62. Foley KM. The treatment of cancer pain. N Engl J Med 1985;313(2):84–95.

    Article  PubMed  CAS  Google Scholar 

  63. Gammaitoni AR, Fine P, Alvarez N, McPherson ML, Bergmark S. Clinical application of opioid equianalgesic data. Clin J Pain 2003;19(5):286–297.

    Article  PubMed  Google Scholar 

  64. Hewitt DJ. The use of NMDA-receptor antagonists in the treatment of chronic pain. Clin J Pain 2000;16(2 Suppl):S73–S79.

    PubMed  CAS  Google Scholar 

  65. Houston AM, Teach SJ. COX-2 inhibitors: a review. Pediatr Emerg Care 2004;20(6):396–399; quiz 400-402.

    Article  PubMed  Google Scholar 

  66. Katz N. Coxibs: Evolving role in pain management. Semin Arthritis Rheum 2002;32(3 Suppl 1):15–24.

    Article  PubMed  CAS  Google Scholar 

  67. Lapin J, Portenoy RK, Coyle N, Houde RW, Foley KM. Guidelines for use of controlledrelease oral morphine in cancer pain management. Correlation with clinical experience. Cancer Nurs 1989;12(4):202–208.

    Article  PubMed  CAS  Google Scholar 

  68. Manfredi PL, Borsook D, Chandler SW, Payne R. Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations. Pain 1997;70(1):99–101.

    Article  PubMed  CAS  Google Scholar 

  69. Monfared H, Sferra JJ, Mekhail N. The medical management of chronic pain. Foot Ankle Clin 2004;9(2):373–403.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

    Vivek Tim Malhotra MD, MPH

Authors
  1. Vivek Tim Malhotra MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY

    Leonard B. Saltz MD

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Malhotra, V.T. (2007). Pain Management in the Colorectal Cancer Patient. In: Markman, M., Saltz, L.B. (eds) Colorectal Cancer. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-59745-215-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-215-1_14

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-751-8

  • Online ISBN: 978-1-59745-215-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation